Cottage Street Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-6,736
Closed -$209K – 97
2020
Q2
$209K Hold
6,736
– – 0.16% 87
2020
Q1
$209K Hold
6,736
– – 0.19% 87
2019
Q4
$250K Sell
6,736
-57
-0.8% -$2.03K 0.14% 90
2019
Q3
$232K Hold
6,793
– – 0.14% 92
2019
Q2
$279K Sell
6,793
-245
-3% -$9.73K 0.17% 81
2019
Q1
$284K Hold
7,038
– – 0.17% 80
2018
Q4
$291K Buy
7,038
+269
+4% +$11.2K 0.19% 76
2018
Q3
$283K Hold
6,769
– – 0.16% 80
2018
Q2
$233K Hold
6,769
– – 0.14% 87
2018
Q1
$228K Hold
6,769
– – 0.14% 83
2017
Q4
$233K Hold
6,769
– – 0.14% 80
2017
Q3
$229K Hold
6,769
– – 0.15% 79
2017
Q2
$216K Hold
6,769
– – 0.15% 80
2017
Q1
$220K Sell
6,769
-291
-4% -$9.18K 0.16% 76
2016
Q4
$218K Hold
7,060
– – 0.17% 77
2016
Q3
$227K Hold
7,060
– – 0.17% 77
2016
Q2
$236K Buy
+7,060
New +$225K 0.19% 75
2016
Q1
– Sell
-7,270
Closed -$233K – 88
2015
Q4
$233K Buy
+7,270
New +$229K 0.21% 80

Other funds holding PFE

Cottage Street Advisors's PFE Position: Q3 2020 in Review

Cottage Street Advisors sold out of Pfizer (PFE) in Q3 2020, closing a stake of 6,736 shares — an estimated $209K sold.

Cottage Street Advisors first reported a position in PFE in Q4 2015 and held it in 18 quarters. The position peaked at $291K in Q4 2018. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Cottage Street Advisors reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
  • Cottage Street Advisors sold 6,736 Pfizer shares in Q3 2020, an estimated $209K.
  • Cottage Street Advisors first reported a position in Pfizer in Q4 2015 and held it in 18 quarters.
  • Cottage Street Advisors's Pfizer position peaked at $291K in Q4 2018.
  • 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Cottage Street Advisors's 13F filing for Q3 2020, filed 8 Oct 2020.